Given its significance in the autophagy signaling pathway, EGOT may be act as a promising predictive biomarker for paclitaxel response, and proper regulation of EGOT may be a novel synergistic strategy for enhancing paclitaxel sensitivity in human cancer. This evidence concerns the gene EGOT and cancer.